comparemela.com

Abbvie Immunogen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Genmab Buys ProfoundBio for $1 8B to Boost Oncology Portfolio

Danish drugmaker Genmab said Wednesday it plans to acquire U.S. biotech firm ProfoundBio for $1.8 billion in cash to expand its cancer treatment portfolio.

vimarsana © 2020. All Rights Reserved.